- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/30 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 235/30
Total number of patents in this class: 407
10-year publication summary
|
31
|
36
|
34
|
28
|
30
|
25
|
20
|
21
|
14
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Translational Drug Development, LLC | 44 |
14 |
| Acesion Pharma ApS | 15 |
12 |
| Corteva Agriscience LLC | 2702 |
11 |
| Biohaven Therapeutics Ltd. | 114 |
10 |
| Bayer Pharma AG | 1048 |
9 |
| VALO Health, Inc. | 176 |
9 |
| vTv Therapeutics LLC | 155 |
8 |
| ADT Pharmaceuticals, LLC | 13 |
8 |
| Boehringer Ingelheim International GmbH | 4636 |
7 |
| Alzprotect | 21 |
7 |
| Universite de Lille 2 droit et Sante | 213 |
6 |
| Board of Regents, The University of Texas System | 5946 |
5 |
| Duke University | 3125 |
5 |
| Blueprint Medicines Corporation | 240 |
5 |
| Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 377 |
5 |
| Omeros Corporation | 310 |
5 |
| Purdue Pharmaceutical Products L.P. | 31 |
5 |
| KPC Pharmaceuticals, Inc. | 26 |
5 |
| Biohaven Therapeutics Ltd. | 132 |
5 |
| Janssen Pharmaceutica N.V. | 3358 |
4 |
| Other owners | 262 |